Sharps Technology Inc. - Common Stock (STSS)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 98% below Graham Number ($112.42) — significant margin of safety
- Piotroski F-Score 3/9 — signs of financial weakness
- Loss-making — negative ROE of -38.4%
Sharps Technology Inc. - Common Stock (STSS) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $72 million . Key value metrics: P/E ratio 0.1, P/B ratio 0.27, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 4 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Sharps Technology Inc. - Common Stock — Fundamental Analysis Summary
Sharps Technology Inc. - Common Stock (STSS) is trading 98% below its Graham Number of $112.42 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 0.1x.
On financial health, STSS shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and negative return on equity of -38.4% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.01.
StockPik's composite Value Score for STSS is 50/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
STSS reports a thin gross margin of -202.5% (sector average: 33.5%) and a negative operating margin of -53,736.8%.
STSS shows earnings declining at 2,939%.